BGNE
Income statement / Annual
Last year (2023), BeiGene, Ltd.'s total revenue was $2.46 B,
an increase of 73.65% from the previous year.
In 2023, BeiGene, Ltd.'s net income was -$881.71 M.
See BeiGene, Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.46 B |
$1.42 B |
$1.18 B |
$308.87 M |
$428.21 M |
$198.22 M |
$238.39 M |
$1.07 M |
$8.82 M |
$13.04 M |
| Cost of Revenue |
$379.92 M
|
$1.93 B
|
$1.62 B
|
$1.37 B
|
$998.53 M
|
$707.71 M
|
$273.99 M
|
$98.03 M
|
$58.25 M
|
$21.86 M
|
| Gross Profit |
$2.08 B
|
-$511.06 M
|
-$447.86 M
|
-$1.06 B
|
-$570.32 M
|
-$509.49 M
|
-$35.61 M
|
-$96.96 M
|
-$49.43 M
|
-$8.83 M
|
| Gross Profit Ratio |
0.85
|
-0.36
|
-0.38
|
-3.42
|
-1.33
|
-2.57
|
-0.15
|
-90.62
|
-5.61
|
-0.68
|
| Research and Development Expenses |
$1.78 B
|
$1.64 B
|
$1.46 B
|
$1.29 B
|
$927.34 M
|
$679.01 M
|
$269.02 M
|
$98.03 M
|
$58.25 M
|
$21.86 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$195.39 M
|
$62.60 M
|
$20.10 M
|
$7.31 M
|
$6.93 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.50 B
|
$1.28 B
|
$990.12 M
|
$600.18 M
|
$388.25 M
|
$195.39 M
|
$62.60 M
|
$20.10 M
|
$7.31 M
|
$6.93 M
|
| Other Expenses |
$3.50 M
|
$751,000.00
|
$750,000.00
|
$846,000.00
|
$1.33 M
|
$1.99 M
|
$11.46 M
|
-$2.49 M
|
-$916,000.00
|
$600,000.00
|
| Operating Expenses |
$3.29 B
|
$1.28 B
|
$990.87 M
|
$601.02 M
|
$389.58 M
|
$196.28 M
|
$62.85 M
|
$20.10 M
|
$7.31 M
|
$6.93 M
|
| Cost And Expenses |
$3.67 B
|
$3.21 B
|
$2.62 B
|
$1.97 B
|
$1.39 B
|
$903.99 M
|
$336.84 M
|
$118.13 M
|
$65.56 M
|
$28.79 M
|
| Interest Income |
$0.00
|
$52.48 M
|
$15.76 M
|
$2.00 M
|
$9.13 M
|
$13.95 M
|
$0.00
|
$0.00
|
$559,000.00
|
$40,000.00
|
| Interest Expense |
$0.00
|
$52.48 M
|
$0.00
|
$0.00
|
$0.00
|
$13.95 M
|
$0.00
|
$383,000.00
|
$1.23 M
|
$3.55 M
|
| Depreciation & Amortization |
$87.68 M
|
$66.28 M
|
$46.46 M
|
$31.79 M
|
$18.62 M
|
$10.39 M
|
$4.76 M
|
$1.91 M
|
$1.55 M
|
$1.56 M
|
| EBITDA |
-$1.12 B |
-$1.72 B |
-$1.39 B |
-$1.63 B |
-$941.27 M |
-$695.38 M |
-$93.70 M |
-$115.15 M |
-$55.20 M |
-$14.20 M |
| EBITDA Ratio |
-0.46
|
-1.26
|
-1.22
|
-5.36
|
-2.24
|
-3.56
|
-0.41
|
-109.4
|
-6.44
|
-1.04
|
| Operating Income Ratio |
-0.49
|
-1.26
|
-1.22
|
-5.37
|
-2.24
|
-3.56
|
-0.41
|
-109.4
|
-6.44
|
-1.21
|
| Total Other Income/Expenses Net |
$381.90 M
|
-$171.37 M
|
$147,000.00
|
$39.49 M
|
$16.31 M
|
$15.94 M
|
$7.39 M
|
-$2.10 M
|
-$357,000.00
|
-$2.79 M
|
| Income Before Tax |
-$825.84 M
|
-$1.96 B
|
-$1.44 B
|
-$1.62 B
|
-$943.59 M
|
-$689.83 M
|
-$91.06 M
|
-$119.16 M
|
-$57.10 M
|
-$18.55 M
|
| Income Before Tax Ratio |
-0.34
|
-1.38
|
-1.22
|
-5.24
|
-2.2
|
-3.48
|
-0.38
|
-111.37
|
-6.48
|
-1.42
|
| Income Tax Expense |
$55.87 M
|
$42.78 M
|
-$25.23 M
|
-$17.67 M
|
$6.99 M
|
-$15.80 M
|
$2.24 M
|
$54,000.00
|
-$2.10 M
|
$3.88 M
|
| Net Income |
-$881.71 M
|
-$2.00 B
|
-$1.41 B
|
-$1.60 B
|
-$950.58 M
|
-$673.77 M
|
-$93.11 M
|
-$119.22 M
|
-$57.10 M
|
-$18.28 M
|
| Net Income Ratio |
-0.36
|
-1.42
|
-1.2
|
-5.18
|
-2.22
|
-3.4
|
-0.39
|
-111.42
|
-6.48
|
-1.4
|
| EPS |
-8.45 |
-1.49 |
-1.17 |
-1.47 |
-1.22 |
-0.93 |
-0.17 |
-0.3 |
-0.14 |
-0.0267 |
| EPS Diluted |
-8.45 |
-1.49 |
-1.17 |
-1.47 |
-1.22 |
-0.93 |
-0.17 |
-0.3 |
-0.14 |
-0.0267 |
| Weighted Average Shares Out |
$104.39 M
|
$1.34 B
|
$1.21 B
|
$1.09 B
|
$780.70 M
|
$720.75 M
|
$543.19 M
|
$403.62 M
|
$409.72 M
|
$684.59 M
|
| Weighted Average Shares Out Diluted |
$104.39 M
|
$1.34 B
|
$1.21 B
|
$1.09 B
|
$780.70 M
|
$720.75 M
|
$543.19 M
|
$403.62 M
|
$409.72 M
|
$684.59 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
